Harvey Alter’s Nobel Prize honors a half-century quest
Nobel laureate Harvey Alter’s work as an NIH hematologist led to profound improvements in blood transfusion safety and starkly reduced transmission of a potentially deadly virus.
Imaging the secret lives of immune cells in the eye
Rochester researchers combine videography and artificial intelligence to track the interactions of microscopic immune cells in a living eye without dyes or damage, a first for imaging science.
Rochester graduate awarded 2020 Nobel Prize for ‘landmark achievement’ against hepatitis
NIH scientist Harvey Alter, who holds BA and MD degrees from Rochester, is the 13th Nobel laureate with ties to the University.
A route to better antibiotics: understanding ‘stressed bacteria’
Rochester biologist Anne S. Meyer’s research into the mechanisms behind bacteria’s responses may lead to more effective antibiotics and less antibiotic resistance.
Quick COVID-detecting nasal swab card, tested at URMC, is approved for use
Evaluated in a clinical trial at the Medical Center, a $5 diagnostic test that quickly detects COVID-19 has received FDA approval for use by health care providers.
Rochester researchers document record-setting optical fiber
The innovative fiber—made of seven capillaries surrounding a hollow core—may be a promising platform for quantum information processing and other applications.
Photonics researchers report breakthrough in miniaturizing light-based chips
A Rochester team demonstrates a new way to control light as it moves through integrated circuits, paving a research avenue in communications, computing, and photonics research.
Experiments replicate high densities in ‘white dwarf’ star remnants
Rochester researchers help lead work to simulate pressures of white dwarf stars, work that may offer ideas for creating new materials on Earth.
Rochester leads effort to understand matter at atom-crushing pressures
The University is the host institution for a NSF-funded national collaboration to explore ‘revolutionary states of matter.’
University joins phase 3 test of coronavirus vaccine
In a collaboration with Rochester Regional Health, the Medical Center delivered the country’s first doses of a potential vaccine to volunteers in a final national trial before FDA approval.